Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids

被引:96
作者
Bruna, A
Nicolàs, M
Muñoz, A
Kyriakis, JM
Caelles, C [1 ]
机构
[1] Univ Barcelona, IRBB PCB, E-08028 Barcelona, Spain
[2] Univ Barcelona, Dept Bioquim & Biol Mol, Div 4, E-08028 Barcelona, Spain
[3] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain
[4] Tufts Univ New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA
关键词
AP-1; antagonism; cell signaling; cross-talk; MAPK docking site; MAPK pathway;
D O I
10.1093/emboj/cdg590
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibition of the c-Jun N-terminal kinase (JNK) pathway by glucocorticoids (GCs) results in AP-1 repression. GC antagonism of AP-1 relies mainly on the transrepression function of the GC receptor (GR) and mediates essential physiological and pharmacological actions. Here we show that GCs induce the disassembly of JNK from mitogen-activated protein kinase kinase 7 (MKK7) by promoting its association with GR. Moreover, we have characterized a hormone-regulated JNK docking site in the GR ligand-binding domain that mediates GR-JNK interaction. The binding of GR to JNK is required for inhibition of JNK activation and induction of inactive JNK nuclear transfer by GCs. The dissociation of these two hormone actions shows that JNK nuclear transfer is dispensable for the downregulation of JNK activation by GCs. Nonetheless, nuclear accumulation of inactive JNK may still be relevant for enhancing the repression of AP-1 activity by GCs. In this regard, chromatin immunoprecipitation assays show that GC-induced GR-JNK association correlates with an increase in the loading of inactive JNK on the AP-1-bound response elements of the c-jun gene.
引用
收藏
页码:6035 / 6044
页数:10
相关论文
共 41 条
  • [31] Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones
    Rogatsky, I
    Zarember, KA
    Yamamoto, KR
    [J]. EMBO JOURNAL, 2001, 20 (21) : 6071 - 6083
  • [32] SAATCIOGLU F, 1994, SEMIN CANCER BIOL, V5, P347
  • [33] Savory JGA, 1999, MOL CELL BIOL, V19, P1025
  • [34] Oncogenic effect of delta deletion in v-Jun does not result from uncoupling Jun from JNK signaling
    Sprowles, A
    Wisdom, R
    [J]. ONCOGENE, 2003, 22 (04) : 498 - 506
  • [35] Docking interactions in the mitogen-activated protein kinase cascades
    Tanoue, T
    Nishida, E
    [J]. PHARMACOLOGY & THERAPEUTICS, 2002, 93 (2-3) : 193 - 202
  • [36] Tournier C, 1999, MOL CELL BIOL, V19, P1569
  • [37] Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo
    Vayssiere, BM
    Dupont, S
    Choquart, A
    Petit, F
    Garcia, T
    Marchandeau, C
    Gronemeyer, H
    RescheRigon, M
    [J]. MOLECULAR ENDOCRINOLOGY, 1997, 11 (09) : 1245 - 1255
  • [38] Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor α in fetal rat hepatocyte primary cultures
    Ventura, JJ
    Roncero, C
    Fabregat, I
    Benito, M
    [J]. HEPATOLOGY, 1999, 29 (03) : 849 - 857
  • [39] Transrepression of c-jun gene expression by the glucocorticoid receptor requires both AP-1 sites in the c-jun promoter
    Wei, P
    Inamdar, N
    Vedeckis, WV
    [J]. MOLECULAR ENDOCRINOLOGY, 1998, 12 (09) : 1322 - 1333
  • [40] JNK phosphorylation relieves HDAC3-dependent suppression of the transcriptional activity of c-Jun
    Weiss, C
    Schneider, S
    Wagner, EF
    Zhang, XH
    Seto, E
    Bohmann, D
    [J]. EMBO JOURNAL, 2003, 22 (14) : 3686 - 3695